ARTELO BIOSCIENCES INC (ARTL)
US04301G5080 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A 133.04% | N/A 109.69% | N/A 44.82% | |||||||||||
| EBITDA YoY % growth | N/A | N/A | N/A | N/A | -2.34M | -3.21M -37.18% | -4.69M -46.11% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -20K | -20K | -30K -50.00% | -230K -666.67% | -2.34M -917.39% | -3.21M -37.18% | -4.69M -46.11% | -7.44M -58.64% | -10.29M -38.31% | -9.93M 3.50% | N/A 2.94% | N/A -16.26% | N/A -62.62% | N/A -31.26% | N/A 150.06% | N/A 421.59% | N/A 166.83% | N/A 54.88% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | -1.01 36.53% | -0.29 71.29% | -3.65 -1,158.62% | -3.19 12.60% | N/A 0.77% | N/A 73.50% | N/A 28.27% | N/A 30.51% | N/A 24.39% | N/A 109.68% | N/A 5,133.33% | N/A 42.68% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.37 64.04% | -0.17 77.77% | -0.17 76.88% | -0.17 50.46% | -0.10 72.73% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -2.534M 21.78% | -2.757M -6.49% | -2.78M -10.65% | -2.802M -134.47% | -2.824M -11.45% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.35 57.83% | -0.47 | 0.12 | 25.94% |
| Q2 2024 Q2Q % growth | -0.75 -33.93% | -0.86 | 0.11 | 13.15% |
| Q1 2024 Q2Q % growth | -0.78 -2.63% | -1.08 | 0.30 | 27.52% |
| Q4 2023 Q2Q % growth | -1.04 11.86% | -0.57 | -0.47 | -83.16% |
| Q3 2023 Q2Q % growth | -0.83 -1.22% | -0.66 | -0.17 | -25.83% |
| Q2 2023 Q2Q % growth | -0.56 37.78% | -0.83 | 0.27 | 32.64% |
| Q1 2023 Q2Q % growth | -0.76 -1.33% | -0.95 | 0.19 | 19.88% |
| Q4 2022 Q2Q % growth | -1.18 -1,585.71% | -0.74 | -0.44 | -58.47% |
| Q3 2022 Q2Q % growth | -0.82 -1,540.00% | -0.93 | 0.11 | 11.98% |
| Q2 2022 Q2Q % growth | -0.90 -2,900.00% | -0.87 | -0.03 | -3.80% |
| Q1 2022 Q2Q % growth | -0.75 -435.71% | -1.30 | 0.55 | 42.33% |
| Q4 2021 Q2Q % growth | -0.07 65.00% | -0.06 | -0.01 | -24.78% |
| Q3 2021 Q2Q % growth | -0.05 81.48% | -0.10 | 0.05 | 49.29% |
| Q2 2021 Q2Q % growth | -0.03 92.50% | -0.09 | 0.06 | 67.32% |
| Q1 2021 Q2Q % growth | -0.14 65.00% | -0.12 | -0.02 | -19.35% |
| Q4 2020 Q2Q % growth | -0.20 33.33% | -0.10 | -0.10 | -96.08% |
| Q3 2020 Q2Q % growth | -0.27 -58.82% | -0.37 | 0.10 | 26.47% |
| Q2 2020 Q2Q % growth | -0.40 -135.29% | -0.41 | 0.01 | 1.96% |
| Q1 2020 Q2Q % growth | -0.40 | -0.54 | 0.14 | 26.01% |
| Q3 2019 Q2Q % growth | -0.17 | -0.52 | 0.35 | 67.32% |
| Q2 2019 Q2Q % growth | -0.17 | -0.43 | 0.26 | 60.32% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -39.24% | -39.24% | -20.17% | -54.01% |
| Revenue | N/A | N/A | N/A | N/A |